Park Kwang-seok Acquires 9,455,845 Shares via Debt-to-Equity Swap... Total Shares Surge 7.5-Fold, Severely Diluting Existing Shareholders
Korea Union Pharm carried out a debt-to-equity swap upon approval of its rehabilitation plan, resulting in a surge in total outstanding shares from 7,912,828 to 59,573,136 (approximately 7.5 times increase).
Largest shareholder Park Kwang-seok acquired 9,455,845 shares (15.87% of new total) at 500 won per share, an 81.6% discount to the previous closing price of 2,725 won.
This swap massively dilutes existing shareholders' equity value; theoretically, the per-share value drops from 2,725 won to approximately 362 won.
Park stated the purpose as simple investment, but the acquisition secures a favorable stake for maintaining management control.
Going forward, stock price is likely to face continued downward pressure due to the massive new supply and low conversion price.
[AI Comprehensive Analysis]This debt-to-equity swap, while necessary for the company's survival under rehabilitation, inflicts severe dilution on existing shareholders. The conversion price is significantly below market, substantially eroding the intrinsic value of existing holdings, and a near-term stock rebound appears unlikely.